Stockreport

CRISPR Therapeutics GAAP EPS of -$1.17 beats by $0.07, revenue of $0.89M [Seeking Alpha]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF Crispr And Intellia: Advancing In Vivo Gene Editing As 2025 Results Strengthen Investment Outlook Crispr: Investors Waiting Patiently For In-Vivo Crispr Therapeutic [Read more]